Caroline M. Loewy

Insider Reports History

Location
Seattle, WA
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Caroline M. Loewy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caroline M. Loewy:

Company Role Class Num Shares Value Price $ Report Date Ownership
PHOENIX BIOTECH ACQUISITION CORP. Director Class A Common Stock 5,828 $58,280 $10.00 14 Feb 2024 Direct
eFFECTOR Therapeutics, Inc. Director Common Stock 9,047 $5,487 $0.6065 09 Sep 2023 Direct
Aptose Biosciences Inc. Former Director Director Stock Option (Right to Buy) 50,000 18 Jan 2022 Direct
PhaseBio Pharmaceuticals Inc Director Non-employee Director Stock Option (right to buy) 17,500 19 May 2022 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 3,750 19 May 2023 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 800 13 Jun 2024 Direct
CymaBay Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 22 Mar 2024 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 19 May 2023 Direct
ZOGENIX, INC. Director Stock Option (Right to Buy) 0 $26.09 07 Mar 2022 Direct

Insider Reports Filed by Caroline M. Loewy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024073213-loewy-caroline-m-2024-06-13 eFFECTOR Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 13 Jun 2024, 18:45
/report/000095017024035474-loewy-caroline-m-2024-03-22 CymaBay Therapeutics, Inc. 22 Mar 2024 10 $0 4 Director 22 Mar 2024, 17:09
/report/000120919124003709-loewy-caroline-m-2024-02-19 eFFECTOR Therapeutics, Inc. 19 Feb 2024 1 $0 4 Director 21 Feb 2024, 17:39
CERO PHOENIX BIOTECH ACQUISITION CORP. 14 Feb 2024 1 $0 4 Director 16 Feb 2024, 19:41
/report/000106299324001419-loewy-caroline-m-2024-01-24 CymaBay Therapeutics, Inc. 24 Jan 2024 1 $0 4 Director 26 Jan 2024, 18:17
/report/000120919123049031-loewy-caroline-m-2023-09-09 eFFECTOR Therapeutics, Inc. 09 Sep 2023 1 $0 4 Director 11 Sep 2023, 20:38
/report/000120919123049027-loewy-caroline-m-2023-09-09 eFFECTOR Therapeutics, Inc. 09 Sep 2023 0 $0 3 Director 11 Sep 2023, 20:36
/report/000116924523000028-loewy-caroline-m-2023-05-19 PhaseBio Pharmaceuticals Inc 19 May 2023 2 $0 4 Director 19 May 2023, 16:16
/report/000106299323001497-loewy-caroline-m-2023-01-25 CymaBay Therapeutics, Inc. 25 Jan 2023 1 $0 4 Director 27 Jan 2023, 15:34
APTOF Aptose Biosciences Inc. 31 May 2022 0 $0 4 Former Director 15 Jun 2022, 14:13
/report/000116924522000062-loewy-caroline-m-2022-05-19 PhaseBio Pharmaceuticals Inc 19 May 2022 2 $0 4 Director 20 May 2022, 16:44
/report/000089924322010295-loewy-caroline-m-2022-03-07 ZOGENIX, INC. 07 Mar 2022 2 $0 4 Director 09 Mar 2022, 18:06
/report/000106299322001692-loewy-caroline-m-2022-01-25 CymaBay Therapeutics, Inc. 25 Jan 2022 1 $0 4 Director 27 Jan 2022, 15:51
APTOF Aptose Biosciences Inc. 18 Jan 2022 1 $0 4 Director 20 Jan 2022, 16:13
CERO PHOENIX BIOTECH ACQUISITION CORP. 08 Oct 2021 1 $0 4 Director 12 Oct 2021, 19:34
CERO PHOENIX BIOTECH ACQUISITION CORP. 05 Oct 2021 0 $0 3 Director 05 Oct 2021, 18:47
/report/000116924521000061-loewy-caroline-m-2021-06-03 PhaseBio Pharmaceuticals Inc 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 18:06
/report/000137515121000060-loewy-caroline-m-2021-05-27 ZOGENIX, INC. 27 May 2021 1 $0 4 Director 28 May 2021, 20:00